Full-Time

KOL Engagement Manager

Updated on 3/14/2025

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Compensation Overview

$75k - $110kAnnually

+ Competitive Compensation Package + Equity Program

Junior, Mid

Company Historically Provides H1B Sponsorship

Alameda, CA, USA

Category
General Marketing
Growth & Marketing
Required Skills
Word/Pages/Docs
Tableau
Salesforce
Marketing
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in Marketing, Business, Communications, or a related field
  • 1+ years of experience in marketing, preferably in the medical device or healthcare industry, or equivalent combination of education and experience
  • Good knowledge of MS Excel and Analytics software (Tableau, Salesforce, etc.)
  • Strong oral, written and interpersonal communication skills
  • High degree of accuracy and attention to detail
  • Proficiency with Microsoft Word, Excel, PowerPoint, and other standard office tools
  • Ability to coordinate remotely via audio/video conferencing
  • Excellent organizational, time management and prioritization skills
  • Ability to interact with team members and customers (internal and external) in a professional manner
  • Ability to set and maintain project delivery timelines with regular updates to key stakeholders
  • Must be creative, self-motivated, team-oriented, proactive, intuitive, organized, collaborative, and flexible
Responsibilities
  • Assist product marketing teams with creating, updating, and managing marketing literature, sales tools, and educational videos
  • Support the creation of marketing materials, including presentations and digital content
  • Manage marketing content, tools, literature, and presentations
  • Collaborate closely with product marketing teams to identify opportunities for new materials and messaging pull through
  • Translate complex ideas and information into clear, actionable recommendations and findings
  • Assist in the creation and management of event-related materials
  • Analyze marketing performance drivers to shape content creation
  • Develop and share key strategic insights through data analysis and visualization
  • Coordinate with internal teams and customers to ensure the timely delivery of materials
  • Maintain marketing calendars and schedules for the vascular franchise
  • Adhere to the Company’s Quality Management System (QMS) as well as domestic and global quality system regulations, standards, and procedures
  • Understand relevant security, privacy and compliance principles and adhere to the regulations, standards, and procedures that are applicable to the Company
  • Ensure other members of the department follow the QMS, regulations, standards, and procedures
  • Perform other work-related duties as assigned
Desired Qualifications
  • Analytical abilities preferred

Penumbra Inc. specializes in creating medical devices aimed at treating neurovascular and peripheral vascular conditions. Their products include a variety of devices for neuro interventions, such as the Penumbra System and the Penumbra SMART COIL, which are used to address issues like stroke. For peripheral vascular diseases, they offer the Indigo System and related devices. These products are designed to assist healthcare professionals in hospitals and clinics, primarily in Europe and the Americas. What sets Penumbra apart from competitors is their focus on continuous research and development, ensuring their devices meet the changing needs of the medical field. The company's goal is to provide effective and high-quality medical solutions that improve patient outcomes in neurovascular and peripheral vascular care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive procedures boosts Penumbra's market potential.
  • Global neurovascular devices market is projected to grow at 8.5% CAGR until 2030.
  • Technological advancements enhance effectiveness of Penumbra's neurovascular treatments.

What critics are saying

  • Leadership gap due to Don Kassing's retirement may affect strategic decisions.
  • Costa Rica manufacturing expansion could face operational challenges and increased costs.
  • Layoffs in Immersive Healthcare division indicate potential strategic instability.

What makes Penumbra Inc unique

  • Penumbra specializes in neurovascular and peripheral vascular medical devices.
  • The company offers innovative solutions for stroke and neurovascular disease treatment.
  • Penumbra's global presence spans North America, Europe, Asia, and Australia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Neuro News International
Feb 28th, 2025
Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access

Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access.

Penumbrainc
Feb 27th, 2025
Penumbra Launches ACCESS25[TM] Delivery Microcatheter Designed for Aneurysm Access and Delivery of Elevated Clinical Benefits

Penumbra recently launched the ACCESS25 Delivery Microcatheter, a single lumen medical device designed to aid physicians in accessing the neurovasculature for the delivery of Penumbra's advanced .020" coil platform.

PR Newswire
Feb 21st, 2025
Penumbra, Inc. Announces Don Kassing Will Retire From Board Of Directors

ALAMEDA, Calif., Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced today that after 17 years of distinguished service, Don Kassing has notified the company that he will retire from the board of directors effective April 1, 2025. Kassing joined Penumbra's Board of Directors in 2008 and has served as Presiding Director since 2015."We are grateful for Don's many contributions to the board over the years, particularly his wisdom and guidance in complex situations and through our phases of growth," said Adam Elsesser, board chair, president and chief executive officer of Penumbra. "We also thank Don for his steadfast leadership and dedication to helping Penumbra advance our mission of helping more and more people over the years."Mr. Kassing is President Emeritus of San Jose State University

Investing.com
Feb 19th, 2025
UBS raises Penumbra stock price target to $320, keeps buy rating

Penumbra plans to expand its manufacturing capacity with a new facility in Costa Rica.

PR Newswire
Feb 18th, 2025
Penumbra, Inc. Reports Fourth Quarter And Full Year 2024 Financial Results

ALAMEDA, Calif., Feb. 18, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2024. Financial Highlights: Adjusted revenue1 of $321.3 million, excluding the $5.8 million impact of the Italian government's payback provision pertaining to prior years, an increase of 12.9% adjusted2 or 13.0% in adjusted constant currency2 compared to the fourth quarter of 2023. Adjusted revenue1 of $1,200.4 million, excluding the $5.8 million impact of the Italian government's payback provision pertaining to prior years, an increase of 13.4% in adjusted2 and adjusted constant currency2 compared to the full year 2023